Revium Rx ratios data for the quarter ended Jun 2026. These financial ratios cover 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Efficiency | ||||
| Assets AverageAssets Avg. | 7.71M | |||
| Invested CapitalInvested Cap. | 19.92M | 6.88M | 5.52M | |
| Leverage & Solvency | ||||
| Debt Ratio | 0.01 | 0.00 | 0.00 | |
| Valuation | ||||
| Price to EarningsP/E | -32.37 | -138.55 | ||
| Price to BookP/B | 1.23 | 1.64 | 4.59 | 18.38 |
| Enterprise Value | 19.78M | 30.36M | 28.87M | 99.91M |
| EV to EBIT | -32.37 | -136.49 | ||
| EV to EBITDA | -32.37 | -136.49 | ||
| Market Capitalization | 24.29M | 30.36M | 31.58M | 101.42M |